United States v. American Therapeutic Corp.

797 F. Supp. 2d 1289, 2011 U.S. Dist. LEXIS 78888, 2011 WL 2746302
CourtDistrict Court, S.D. Florida
DecidedJanuary 28, 2011
DocketCase 10-23765-CIV
StatusPublished
Cited by5 cases

This text of 797 F. Supp. 2d 1289 (United States v. American Therapeutic Corp.) is published on Counsel Stack Legal Research, covering District Court, S.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. American Therapeutic Corp., 797 F. Supp. 2d 1289, 2011 U.S. Dist. LEXIS 78888, 2011 WL 2746302 (S.D. Fla. 2011).

Opinion

AMENDED 1 ORDER GRANTING PRELIMINARY INJUNCTION AND DENYING MOTIONS TO DISSOLVE THE TEMPORARY RESTRAINING ORDER

JOSE L. MARTINEZ, District Judge.

THIS CAUSE came before the Court upon the United States’s Motion for Preliminary Injunction (D.E. No. 3), Intervenor Hector Negron’s Motion to Dissolve or Modify Temporary Restraining Order (D.E. No. 34), and Defendant Judith Negron’s Motion to Dissolve or Modify Temporary Restraining Order or Alternatively, for Release of Funds for Attorney’s Fees and Costs of Defense. The United States has filed a complaint, alleging that Defendants committed a Federal health care offense, as defined in 18 U.S.C. § 24, by attempting to execute and actually executing a scheme or artifice to defraud a health care benefit program, namely Medicare, in connection with the delivery of or payment for health care benefits, items, or services, in violation of 18 U.S.C. § 1347. The Court has taken judicial notice of the indictment filed in this Court against Defen *1291 dants Duran, Valera, Negron, Acevedo, ATC, and MedLink, in United States v. Duran, et al., No. 10-20767-CR-King.

The Court has already entered a Temporary Restraining Order against all Defendants. See (D.E. No. 10). 2 A default preliminary injunction has been entered against the corporate defendants. See (D.E. No. 28). 3 In addition, the parties stipulated to the entry of a preliminary injunction against Defendant Margarita Acevedo. See (D.E. No. 43). Thus, the motion for a preliminary injunction remains pending against Defendants Lawrence Duran, Marianella Val-era, and Judith Negron (“Defendant Negron”) (collectively “Defendants”).

On January 11, 2011, the Court held an evidentiary hearing on the motion for a preliminary injunction, Intervenor Hector Negron’s (“Intervenor Negron”) motion to dissolve the temporary restraining order, and Defendant Negron’s motion to dissolve the temporary restraining order or alternatively for release of funds. After careful consideration and for the reasons set forth below, the Court grants the United States’s Motion for Preliminary Injunction and denies Intervenor Negron’s motion and Defendant Negron’s motion.

I. Motion for Preliminary Injunction

Plaintiff seeks to enjoin Defendants’ fraudulent activities and to enjoin the dissipation of assets. Specifically, Plaintiff seeks this injunction under 18 U.S.C. § 1345(a)(1), which provides that where a person is “committing or about to commit a Federal health care offense ... the Attorney General may commence a civil action ... to enjoin such violation,” and under 18 U.S.C. § 1345(a)(2), which provides that “[i]f a person is alienating or disposing of property or intends to alienate or dispose of property, obtained as a result of ... a Federal health care offense or property which is traceable to such violation, the Attorney General may commence a civil action in any Federal Court ... to enjoin such alienation or disposition of property.”

“Traditionally, to receive injunctive relief, the moving party must demonstrate (1) likelihood of success on the merits, (2) threat of immediate irreparable harm, (3) that the balance of hardships and the public interest are in his favor.” United States v. Medina, 718 F.Supp. 928, 930 (S.D.Fla.1989). However, here, the conduct at issue is prohibited by statute. “Where ... the statute was enacted to protect the public interest and itself authorizes injunctive relief, ‘[t]he passage of the statute is in a sense, an implied finding that violations will harm the public and ought, if necessary to be restrained.’ ” Id. (quoting United States v. Diapulse Corp., 457 F.2d 25, 27 (2d Cir.1972)). Thus, the Government does not have to show irreparable harm or balance the parties’ interests. Instead, “the requirements for injunctive relief are met ‘when the government establishes that defendants have violated the statute and ... [there] exists some cognizable danger of recurrent violation.’” Medina, 718 F.Supp. at 930 (quoting United States v. Sene X Eleemosynary Corp., 479 F.Supp. 970, 981 (S.D.Fla.1979) (internal quotations omitted)). Here, the Court finds that the Government has offered sufficient evidence at the preliminary injunction stage to show that Defendants violated the statutes at *1292 issue and to show that there is a danger of recurrent violation.

First, the Court finds that the Government has offered sufficient evidence that Defendants committed Federal health care fraud. The United States alleges that the individual Defendants owned and operated the corporate Defendants as community mental health clinics that were supposed to provide psychiatric partial hospitalization programs for the mentally ill, but instead used those entities to perpetrate a massive fraud upon the Medicare program. The United States also alleges that the Defendants collectively received over $85,000,000 from Medicare as a result of their fraud. As discussed below, the Court finds that the government has more than met its burden of proving these allegations.

The Defendants Duran, Valera, and Negron owned and controlled the corporate Defendants, American Therapeutic Corporation (“ATC”), MedLink Professional Management Group, Inc. (“Med-Link”), American Sleep Institute, Inc. (“ASI”), and D & V Development, Inc. (“D & V”). (D.E. No. 5, Baily Decl. at ¶¶ 5-19); see also (D.E. No. 47 at 1); (D.E. No. 45 at 1-2); (D.E. No. 46 at 3). ATC submitted claims to Medicare that resulted in Medicare paying ATC approximately $83,021, 115.54. (D.E. No. 5, Bailey Deck at ¶ 48). In addition, ASI submitted claims to Medicare that resulted in Medicare paying ASI approximately $1,951,200.35. Id. at ¶ 51. ATC and ASI were used as vehicles to perpetrate a fraud on the medicare program which included (1) “conspiring to submit and submitting false claims to the Medicare Program that were tainted by illegal kickback payments; (2) conspiring to submit and submitting false claims and statements to the Medicare Program for medically unnecessary ... [partial hospitalization program] services provided by ATC and sleep study services provided by ASI; (3) making false statements and claims in Medicare cost reports where ATC failed to disclose related party transactions; and (4) engaging in fraudulent transfers to convert Medicare funds to ill gotten personal gains.” Id. at ¶ 43; see also id. at ¶¶ 44-74. The Court also finds the testimony of Special Agent Mejia on this matter credible. Thus, the Court finds that the government has met its burden to show a Federal health care offense has been committed.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Khan
S.D. Florida, 2023
United States v. Luis
966 F. Supp. 2d 1321 (S.D. Florida, 2013)
United States v. Ocala Live Stock Market, Inc.
861 F. Supp. 2d 1328 (M.D. Florida, 2012)
United States v. Speqtrum, Inc.
District of Columbia, 2012

Cite This Page — Counsel Stack

Bluebook (online)
797 F. Supp. 2d 1289, 2011 U.S. Dist. LEXIS 78888, 2011 WL 2746302, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-american-therapeutic-corp-flsd-2011.